Skip to content
healthcare.dev

EDURANT

NDC 59676-278, rilpivirine hydrochloride, tablet, film coated, from Janssen Products, LP.

Product NDC
59676-278
Status
Listed
Labeler
Janssen Products, LP
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA202022
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59676-278 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RILPIVIRINE HYDROCHLORIDE25 mg/1

Pharmacologic classes

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Non-Nucleoside Analog [EXT]; Non-Nucleoside Reverse Transcriptase Inhibitors [MoA]

Package NDCNDC-11Package
59676-278-015967602780130 TABLET, FILM COATED in 1 BOTTLE (59676-278-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/03880372-2c68-45c6-a53a-f420c49541d6
  • NADAC price for package 59676027801

    GET /v1/drugs/nadac/59676027801

Use it

Look up 59676-278 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59676-278 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59676-278. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.